-+ 0.00%
-+ 0.00%
-+ 0.00%

Medifast Q3 net loss widens to $17.51 million; Q3 revenue falls 19% to $72.05 million

PUBT·10/26/2026 12:12:43
Listen to the news
Medifast Q3 net loss widens to $17.51 million; Q3 revenue falls 19% to $72.05 million
  • Medifast's third-quarter 2026 net loss widened to $17.51 million.
  • Revenue fell 19% to $72.05 million, driven by fewer active earning coaches, whose number dropped 48% to 10,200.
  • The company launched its Trilivy metabolic health system, Reset Fuelings product line and new coach compensation plan.
  • Fourth-quarter 2026 guidance calls for revenue of $55 million to $75 million and income per share of $0.00 to $0.25.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medifast Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610260805BIZWIRE_USPR_____20261026_BW870184) on October 26, 2026, and is solely responsible for the information contained therein.